Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2902
Gene Symbol: GRIN1
GRIN1
0.410 GeneticVariation phenotype BEFREE Clinical features of de novo GRIN1 mutations include infantile involuntary movements, seizures, and hand stereotypies, suggesting that GRIN1 mutations cause encephalopathy resulting in seizures and movement disorders. 25864721 2015
Entrez Id: 9091
Gene Symbol: PIGQ
PIGQ
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 8621
Gene Symbol: CDK13
CDK13
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 9757
Gene Symbol: KMT2B
KMT2B
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 814
Gene Symbol: CAMK4
CAMK4
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 2774
Gene Symbol: GNAL
GNAL
0.020 GeneticVariation phenotype BEFREE GNAL mutations have been shown to cause adult-onset isolated dystonia, a disabling movement disorder characterized by involuntary muscle contractions causing twisting and repetitive movements or abnormal postures. 24408567 2014
Entrez Id: 55145
Gene Symbol: THAP1
THAP1
0.020 GeneticVariation phenotype BEFREE The transcription factor THAP1 (THanatos Associated Protein 1) has emerged recently as the cause of DYT6 primary dystonia, a type of rare, familial and mostly early-onset syndrome that leads to involuntary muscle contractions. 22844099 2012
Entrez Id: 2774
Gene Symbol: GNAL
GNAL
0.020 GeneticVariation phenotype BEFREE GNAL loss-of-function mutations are causally-associated with isolated dystonia, a movement disorder characterized by involuntary muscle contractions leading to abnormal postures. 31034808 2019
Entrez Id: 3708
Gene Symbol: ITPR1
ITPR1
0.010 GeneticVariation phenotype BEFREE All affected members present with cognitive impairment and two of them with mild intermittent involuntary movements in association with the clinical hallmarks of SCA15 (gait ataxia, balance impairment, and dysarthria). 21382133 2011
Entrez Id: 4051
Gene Symbol: CYP4F3
CYP4F3
0.010 GeneticVariation phenotype BEFREE Schizophrenia patients who carry the dopamine D3gly allele and the cytochrome P 450 17alpha-hydroxylase A2-A2 genotype may be more likely to develop abnormal orofoacial and distal involuntary movements and to be incapacitated by these movements when chronically exposed to classical antipsychotic drugs. 11839369 2002
Entrez Id: 1630
Gene Symbol: DCC
DCC
0.010 GeneticVariation phenotype BEFREE Humans with heterozygous mutations in the axon guidance receptor DCC display congenital mirror movements (MMs), which are involuntary movements of body parts, such as fingers, on one side of the body that mirror voluntary movement of the opposite side. 28691197 2018
Entrez Id: 1436
Gene Symbol: CSF1R
CSF1R
0.010 GeneticVariation phenotype BEFREE It also showed that involuntary movements and brainstem or cerebellar atrophy were negative predictors of a CSF1R-mutation-positive result. 31520500 2020
Entrez Id: 9900
Gene Symbol: SV2A
SV2A
0.010 GeneticVariation phenotype BEFREE In addition, a recent clinical study demonstrated that a missense mutation in the SV2A gene caused intractable epilepsy with involuntary movements and developmental retardation, illustrating a causative role of SV2A dysfunction in epilepsy. 28393712 2017
Entrez Id: 9423
Gene Symbol: NTN1
NTN1
0.010 GeneticVariation phenotype BEFREE Here, we have identified 3 mutations in exon 7 of NTN1 in 2 unrelated families and 1 sporadic case with isolated congenital mirror movements (CMM), a disorder characterized by involuntary movements of one hand that mirror intentional movements of the opposite hand. 28945198 2017
Entrez Id: 2775
Gene Symbol: GNAO1
GNAO1
0.010 GeneticVariation phenotype BEFREE Our study demonstrated that GNAO1 variants can cause involuntary movements and severe developmental delay with/without seizures, including various types of early-onset epileptic encephalopathy. 25966631 2016
Entrez Id: 116150
Gene Symbol: NUS1
NUS1
0.010 GeneticVariation phenotype BEFREE Our study strongly supports the finding that this recurrent, de novo, variant in NUS1 causes developmental and epileptic encephalopathy with involuntary movement, ataxia and scoliosis. 31656175 2019
Entrez Id: 2902
Gene Symbol: GRIN1
GRIN1
0.410 Biomarker phenotype GENOMICS_ENGLAND Novel homozygous missense variant of GRIN1 in two sibs with intellectual disability and autistic features without epilepsy. 28051072 2017
Entrez Id: 2902
Gene Symbol: GRIN1
GRIN1
0.410 Biomarker phenotype HPO
Entrez Id: 1356
Gene Symbol: CP
CP
0.310 Biomarker phenotype CTD_human Aceruloplasminemia, an inherited disorder of iron metabolism. 12572680 2003
Entrez Id: 1356
Gene Symbol: CP
CP
0.310 Biomarker phenotype BEFREE Three sporadic patients (two men and one woman) were examined with involuntary movements and dysarthria associated with abnormal concentrations of serum copper, serum ceruloplasmin, and urinary copper excretion. 11723201 2001
Entrez Id: 5173
Gene Symbol: PDYN
PDYN
0.300 Biomarker phenotype CTD_human Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease. 21984936 2011
Entrez Id: 1813
Gene Symbol: DRD2
DRD2
0.300 Biomarker phenotype CTD_human Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. 16435402 2006
Entrez Id: 3356
Gene Symbol: HTR2A
HTR2A
0.300 Biomarker phenotype CTD_human Susceptibility to neuroleptic-induced tardive dyskinesia and the T102C polymorphism in the serotonin type 2A receptor. 11526996 2001
Entrez Id: 4988
Gene Symbol: OPRM1
OPRM1
0.300 Biomarker phenotype CTD_human Genotype and smoking history affect risk of levodopa-induced dyskinesias in Parkinson's disease. 16435402 2006
Entrez Id: 284111
Gene Symbol: SLC13A5
SLC13A5
0.100 Biomarker phenotype HPO